For a patient on NPH insulin 5 units AM and 5 units at bedtime, metformin 750 mg twice daily, and Novolin R (regular insulin) 6 units before each meal with a sliding‑scale of 1 unit for glucose 200–250 mg/dL, and recent glucose readings of 158 mg/dL at 6 AM, 79 mg/dL at 8:35 PM, 191 mg/dL at 3 PM, 305 mg/dL at noon, 199 mg/dL at 5 AM, and 126 mg/dL the night before, how should the insulin doses be adjusted?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 4, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Insulin Dose Adjustment Recommendation

Reduce the bedtime NPH insulin dose by 1 unit (from 5 units to 4 units at bedtime) to address the nocturnal hypoglycemia (79 mg/dL at 8:35 PM), and increase the noon Novolin R dose by 2 units (from 6 units to 8 units before lunch) to address the severe postprandial hyperglycemia (305 mg/dL at noon). 1

Analysis of Glucose Pattern

Your patient's glucose readings reveal two distinct problems:

  • Nocturnal hypoglycemia: The 79 mg/dL reading at 8:35 PM indicates the bedtime NPH is causing excessive glucose lowering overnight
  • Severe postprandial hyperglycemia at lunch: The 305 mg/dL at noon represents inadequate prandial insulin coverage for the midday meal
  • Acceptable morning fasting glucose: The 158 mg/dL at 6 AM is reasonable, though could be optimized further once hypoglycemia is resolved
  • Afternoon hyperglycemia: The 191 mg/dL at 3 PM suggests the lunch insulin dose is insufficient

Rationale for Dose Adjustments

Bedtime NPH Reduction

The 2025 ADA Standards of Care explicitly state: "For hypoglycemia: determine cause; if no clear reason, lower dose by 10-20%" 1. A 1-unit reduction from 5 units represents a 20% decrease, which is appropriate for addressing the documented nocturnal hypoglycemia. The bedtime NPH peaks 4-12 hours after injection 2, meaning the 8:35 PM low glucose (approximately 14-15 hours after the morning dose and 2-3 hours after the bedtime dose) is likely caused by the evening NPH dose.

Noon Prandial Insulin Increase

The 305 mg/dL reading at noon—occurring approximately 2-3 hours after the breakfast meal—represents severe postprandial hyperglycemia. According to ADA guidelines, when A1C remains above goal with basal insulin, "increase dose by 1-2 units insulin dose or 10-15%" for prandial insulin 1. A 2-unit increase (from 6 to 8 units) represents a 33% increase, which is justified given the glucose level exceeds 300 mg/dL—a threshold the guidelines identify as requiring prompt intervention 1.

Important Caveats

Hypoglycemia Takes Priority

Addressing hypoglycemia must be the first priority before intensifying other insulin doses 1. The nocturnal low of 79 mg/dL poses immediate risk for severe hypoglycemia, which can lead to loss of consciousness, seizures, or death 3. The ADA guidelines emphasize that hypoglycemia management supersedes glycemic targets.

NPH Pharmacokinetics

NPH insulin has a peak action 4-12 hours after injection with duration up to 24 hours 2. The morning NPH dose (5 units at 5-6 AM) would peak around 9 AM-6 PM, potentially contributing to the afternoon glucose of 191 mg/dL being relatively controlled. However, the bedtime dose is clearly excessive for overnight needs.

Monitoring Plan

After making these adjustments:

  • Check fasting glucose daily to ensure the bedtime NPH reduction doesn't cause excessive morning hyperglycemia
  • Check pre-lunch and 2-hour post-lunch glucose for 3-5 days to assess the increased noon Novolin R dose
  • Continue checking bedtime glucose to confirm resolution of nocturnal hypoglycemia
  • If fasting glucose rises above 180 mg/dL consistently, consider increasing morning NPH by 1 unit 1

Alternative Consideration: Switching to Twice-Daily NPH

If glucose control remains suboptimal after these adjustments, the ADA guidelines recommend "consider converting to twice-daily NPH plan" when adding prandial insulin to bedtime NPH 1. This would involve:

  • Total NPH dose = 80% of current bedtime NPH (approximately 8 units total)
  • 2/3 given before breakfast (approximately 5 units)
  • 1/3 given before dinner (approximately 3 units)
  • This can be mixed with the Novolin R in the same syringe 3

However, this conversion should wait until the current hypoglycemia is resolved and you've optimized the simpler regimen first.

Why Not Adjust Other Doses?

  • Morning NPH (5 units AM): The afternoon glucose of 191 mg/dL and evening glucose of 126 mg/dL suggest this dose is appropriate. The morning fasting glucose of 158 mg/dL is acceptable given the need to avoid nocturnal hypoglycemia.
  • Breakfast and dinner Novolin R (6 units each): Insufficient data to assess these doses. The 3 PM reading (191 mg/dL) occurs too late to reflect breakfast insulin effect, and no post-dinner glucose is provided.

The metformin 750 mg BID should be continued unchanged as it provides complementary glucose-lowering without increasing hypoglycemia risk and helps limit weight gain 4.

Related Questions

How should the insulin regimen be adjusted for a patient currently receiving Novolin 70/30 (70% NPH, 30% regular insulin) 24 units in the morning and 28 units at night?
For a 60‑kg breastfeeding patient with an HbA1c of 10.2%, is it appropriate to start 10 units of NPH (neutral protamine Hagedorn) insulin at bedtime and 500 mg of metformin with breakfast?
I take 28 units of insulin glargine (basal insulin) once daily in the morning and my hemoglobin A1c is 7.1%; should I continue this dose or adjust it?
For a 25‑year‑old woman at 28 weeks gestation with type 2 diabetes, weight 114 kg, on insulin glargine (Lantus) 32 U daily, insulin‑to‑carbohydrate ratio 1 U:5 g, and insulin sensitivity factor 1 U:25 mg/dL, who ate 55 g carbohydrate at 6 pm and had blood glucose 183 mg/dL at 9 pm and fasting glucose 187 mg/dL, how should her insulin sensitivity factor, insulin‑to‑carbohydrate ratio, and basal insulin dose be adjusted?
A patient taking 30 units of insulin glargine (Lantus) at bedtime has fasting glucose around 215 mg/dL; how much should the insulin dose be increased?
What does an elevated fasting insulin level of 33 µU/mL indicate?
What is the recommended progesterone regimen for luteal‑phase support in IVF cycles, including dosage, route, timing, and duration?
Can anti‑double‑stranded DNA (dsDNA) antibodies be positive in drug‑induced lupus?
What are the side effects of delta‑sleep‑inducing peptide (DSIP) and retatrutide?
What are the recommended dosing regimens for tretinoin, both as a topical cream/gel for acne or photodamage and as an oral agent for acute promyelocytic leukemia?
Do breast cysts fluctuate in size and resolve spontaneously?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.